Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the effect of rutin and vitamin C on selected oxidative
stress and inflammatory markrers.
Patients will be recruited according to the inclusion and exclusion criteria and will be
divided into 3 groups, Group 1: Patients will administer a combination of Vitamin C and Rutin
(RUTA C 60 tablets) in a dose of 2 tablets 3 times daily for 4 months in addition to their
standard therapy, Group 2: will administer vitamin C 500mg hard gelatin capsules (twice
daily) in addition to their standard therapy for a period of 4 months, Group3 (Control group)
will administer the standard therapy. Blood samples will be withdrawn for measurement of;
MDA, TNF-α ,GSH-PX, C-RP levels and ESR.